{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:51Z","timestamp":1790622111565,"version":"4.1.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/dad.0000000000000439","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T01:20:01Z","timestamp":1449019201000},"page":"423-433","source":"Crossref","is-referenced-by-count":27,"title":["Histopathology of the Exanthema in DRESS Is Not Specific but May Indicate Severity of Systemic Involvement"],"prefix":"10.1097","volume":"38","author":[{"given":"Margarida M.","family":"Gon\u00e7alo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel P.","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Gameiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar E.","family":"Tellechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking","volume":"36","author":"Walsh","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","article-title":"Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"37","author":"Descamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Jt Bone Spine"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsivant hypersensitivity syndrome and human herpes virus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2230.2010.03820.x","article-title":"Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions","volume":"35","author":"Hirahara","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/bjd.12169","article-title":"Thyroid dysfunction in drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of systemic drug hypersensitivity","volume":"168","author":"Cookson","year":"2013","journal-title":"Br J Dermatol"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/bjd.12456","article-title":"DRESS (drug reaction with eosinophilia and systemic symptoms) and thyroiditis: HHV-6, the possible link","volume":"169","author":"Descamps","year":"2013","journal-title":"Br J Dermatol"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2340\/00015555-1317","article-title":"Herpes zoster in patients with drug-induced hypersensitivity syndrome\/DRESS","volume":"14","author":"Kano","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000335624","article-title":"Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management","volume":"97","author":"Shiohara","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol induced DRESS and SJS\/TEN in a Portuguese population","volume":"169","author":"Gon\u00e7alo","year":"2013","journal-title":"Br J Dermatol"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2011.12.002","article-title":"The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity","volume":"65","author":"Hanafusa","year":"2012","journal-title":"J Dermatol Sci"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms (DRESS): a morphologic and phenotypic study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2133.2012.10921.x","article-title":"Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome","volume":"147","author":"Saito","year":"2012","journal-title":"Br J Dermatol"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","article-title":"Identification of thymus and activation-regulated chemokine (TARC\/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)\/drug rash with eosinophilia and systemic sym","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jdermsci.2014.01.007","article-title":"TNF-\u03b1 as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"74","author":"Uno","year":"2014","journal-title":"J Dermatol Sci"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.12948","article-title":"Elevated serum thymus and activation-regulated chemokine (TARC\/CCL17) relates to reactivation of human herpesvirus 6 in drug reactions with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS)","volume":"171","author":"Ogawa","year":"2014","journal-title":"Br J Dermatol"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms. A retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2011.1300","article-title":"Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone","volume":"21","author":"Natkunarajah","year":"2011","journal-title":"Eur J Dermatol"},{"key":"R30-5-20210202","first-page":"291","article-title":"Histopathology spectrum of drug reaction with eosinophilia and systemic symptoms (DRESS): a diagnosis that needs a clinicopathological correlation","volume":"149","author":"Borroni","year":"2014","journal-title":"G Ital Dermatol Venerol"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/DAD.0b013e31820a285d","article-title":"Histopathologic features of exanthematous drug eruptions of the macular and papular type","volume":"33","author":"Naim","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2013.06.022","article-title":"Drug-induced exanthems: correlation of allergy testing with histologic diagnosis","volume":"69","author":"Seitz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(85)90918-3","article-title":"Adverse drug reaction monitoring: doing it the French way","volume":"9","author":"Moore","year":"1985","journal-title":"Lancet"},{"key":"R34-5-20210202","first-page":"111","article-title":"Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12788\/j.sder.0057","article-title":"Epidemiology of severe drug hypersensitivity","volume":"33","author":"Dodiuk-Gad","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"R36-5-20210202","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2012.10894.x","article-title":"Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong","volume":"167","author":"Chiu","year":"2012","journal-title":"Br J Dermatol"},{"key":"R38-5-20210202","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","article-title":"Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01","volume":"192","author":"Yun","year":"2014","journal-title":"J Immunol"},{"key":"R39-5-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1056\/NEJM197203092861002","article-title":"Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.","volume":"286","author":"Boston Collaborative Drug Surveillance Program","year":"1972","journal-title":"N Engl J Med"},{"key":"R40-5-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2125.2010.03685.x","article-title":"Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization","volume":"70","author":"Ben Fredj","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"R41-5-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1684\/ejd.2010.0821","article-title":"Amoxicillin-induced flares in patients with DRESS (drug reaction with eosinophilia and systemic symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on human herpes virus 6 replication in vitro","volume":"20","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatol"},{"key":"R42-5-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/00015550410024094","article-title":"Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells","volume":"85","author":"Hashizume","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R43-5-20210202","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/1346-8138.12590","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma","volume":"41","author":"Sueki","year":"2014","journal-title":"J Dermatol"},{"key":"R44-5-20210202","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class-I restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"R45-5-20210202","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: models of T-cell stimulation","volume":"71","author":"Adam","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R46-5-20210202","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1021\/tx400060p","article-title":"T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms","volume":"26","author":"Bell","year":"2013","journal-title":"Chem Res Toxicol"},{"key":"R47-5-20210202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archderm.141.6.683","article-title":"Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis","volume":"141","author":"Quinn","year":"2005","journal-title":"Arch Dermatol"},{"key":"R48-5-20210202","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jaad.2011.10.007","article-title":"Prognostic value of histologic features of toxic epidermal necrolysis","volume":"68","author":"Valeyrie-Allanore","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R49-5-20210202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R50-5-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"R51-5-20210202","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"key":"R52-5-20210202","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1398-9995.2011.02677.x","article-title":"NKp46+ cells express granulysin in multiple cutaneous adverse drug eruptions","volume":"66","author":"Schlapbach","year":"2011","journal-title":"Allergy"},{"key":"R53-5-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0625.2010.01176.x","article-title":"Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in toxic epidermal necrolysis","volume":"20","author":"Araujo","year":"2011","journal-title":"Exp Dermatol"},{"key":"R54-5-20210202","first-page":"577","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system","volume":"14","author":"Criado","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"R55-5-20210202","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcv.2014.08.025","article-title":"Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: a case report","volume":"61","author":"Mine","year":"2014","journal-title":"J Clin Virol"},{"key":"R56-5-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/all.12138","article-title":"Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy","volume":"68","author":"Hashizume","year":"2013","journal-title":"Allergy"},{"key":"R57-5-20210202","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1684\/ejd.2011.1550","article-title":"Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS)","volume":"21","author":"Wei","year":"2011","journal-title":"Eur J Dermatol"},{"key":"R58-5-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.06.003","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases","volume":"52","author":"Abe","year":"2008","journal-title":"J Dermatol Sci"},{"key":"R59-5-20210202","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R60-5-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tox.2003.09.004","article-title":"Drug hypersensitivity reactions in the skin: understanding mechanisms and the development of diagnostic and predictive tests","volume":"15","author":"Naisbitt","year":"2004","journal-title":"Toxicology"},{"key":"R61-5-20210202","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2222.2007.02699.x","article-title":"Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema","volume":"37","author":"Tapia","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"R62-5-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0151-9638(05)79235-8","article-title":"M\u00e9canismes immunologiques des r\u00e9actions cutan\u00e9es aux m\u00e9dicaments","volume":"132","author":"Poszeczynska-Guign\u00e9","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"R63-5-20210202","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"key":"R64-5-20210202","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/clpt.2011.79","article-title":"Phenotype standardization for immune-mediated drug-induced skin injury","volume":"89","author":"Pirmohamed","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R65-5-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archdermatol.2011.147","article-title":"Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature","volume":"147","author":"Peermohamed","year":"2011","journal-title":"Arch Dermatol"},{"key":"R66-5-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1346-8138.12028","article-title":"Pustular-type drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement","volume":"40","author":"Matsuda","year":"2013","journal-title":"J Dermatol"},{"key":"R67-5-20210202","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3892\/etm.2013.944","article-title":"Purulent bullous epidermal necrolysis: a potential new clinical pattern of drug eruption","volume":"5","author":"Liu","year":"2013","journal-title":"Exp Ther Med"},{"key":"R68-5-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-7-72","article-title":"Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?","volume":"7","author":"Bouvresse","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R69-5-20210202","doi-asserted-by":"crossref","first-page":"O6","DOI":"10.1186\/2045-7022-4-S3-O6","article-title":"Overlap between maculopapular exanthema and DRESS among cutaneous adverse drug reactions in a dermatology ward (2008\u20132012)","volume":"4","author":"Gouveia","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"R70-5-20210202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2340\/00015555-1310","article-title":"Toxic epidermal necrolysis arising as a sequela of drug-induced hypersensitivity syndrome","volume":"92","author":"Watanabe","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"R71-5-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000335625","article-title":"Acute generalized exanthematous pustulosis","volume":"97","author":"Sidoroff","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"R72-5-20210202","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archdermatol.2011.239","article-title":"High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"147","author":"Nakajima","year":"2011","journal-title":"Arch Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000000439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:02:21Z","timestamp":1620950541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201606000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000439","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}